133rd Annual Shattuck Lecture — Assessing Therapeutic Responses in Infectious Diseases
Wednesday, May 24, 2023, 12:00 to 1:00 p.m. – Virtual Live Webinar
**This event is part of the MMS Annual Meeting. You will be directed to the Annual Meeting Registration page to register for this and other events being offered.**
Activity Description
The primary objective of anti-infective drug treatment is to save life in life-threatening illness, and control or clear the infection as safely and rapidly as possible in less serious infections. Prevention of spread and resistance are important secondary
considerations. Serial quantitation of the pathogen in body fluids allows pharmacometric evaluation and informs choice of drug and optimization of dose and duration of therapy. Parasitic, fungal, and viral infections can often be quantitated accurately
in-vivo and evaluated in this way. This Lecture will focus primarily on the treatment of malaria and COVID-19 as examples.
Shattuck Lecturer
Nicholas John White, OBE, KCMG, MD, DSc, FRCP, FMedSci, FBPhS, FRS
Professor of Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Thailand & Oxford University, UK
Consultant Physician, Acute General Medicine, John Radcliffe Hospital, Oxford
Wellcome Trust Principal Research Fellow; Chair, Wellcome Trust Tropical Medicine Research Programmes, South East Asia
To learn more about Professor Sir Nicholas John White, FRS, click here.
Activity Objectives
Upon completion of this activity, learners should be able to:
-
Identify methods that may be used to quantitate infections in-vivo
-
Interpret results of evaluation data to guide decisions on optimal therapeutic treatments
-
Describe how pharmacometrics characterization informs drug development
Program Fees:
Massachusetts Medical Society (MMS) Physician Member – $75.00
Non-Member Physician – $150.00
MMS Resident/Student Member – Free
MMS Alliance Member – Free
Allied Health Professional/Other – $60.00
*Click here for
member educational voucher information
Accreditation Statement
The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Actual AMA PRA Category 1 CreditsTM awarded will depend on duration of the activity and may be adjusted accordingly.
